0001209191-22-005556.txt : 20220131
0001209191-22-005556.hdr.sgml : 20220131
20220131160012
ACCESSION NUMBER: 0001209191-22-005556
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220127
FILED AS OF DATE: 20220131
DATE AS OF CHANGE: 20220131
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BREITMEYER JAMES B
CENTRAL INDEX KEY: 0001244823
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50549
FILM NUMBER: 22573898
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oncternal Therapeutics, Inc.
CENTRAL INDEX KEY: 0001260990
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 621715807
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12230 EL CAMINO REAL
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 434-1113
MAIL ADDRESS:
STREET 1: 12230 EL CAMINO REAL
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: GTX INC /DE/
DATE OF NAME CHANGE: 20030822
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-01-27
0
0001260990
Oncternal Therapeutics, Inc.
ONCT
0001244823
BREITMEYER JAMES B
12230 EL CAMINO REAL, SUITE 300
SAN DIEGO
CA
92130
1
1
0
0
Chief Executive Officer
Common Stock
2022-01-27
4
P
0
25000
1.6832
A
46544
I
By Family Trust
Common Stock
384149
D
Common Stock
6493
I
By Spouse
Common Stock
733
I
By Child
The reported price is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $1.66 to $1.85. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares purchased at each price within the range set forth above.
This Form 4 corrects the number of RSUs awarded on January 3, 2022 held by the Reporting Person's spouse erroneously reported as 6,793 due to clerical error.
/s/Chase C. Leavitt, Attorney-in-fact
2022-01-31